Rank | Gene Set | Z-score |
---|---|---|
1 | L-phenylalanine catabolic process (GO:0006559) | 6.03547261 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.03547261 |
3 | negative regulation of fibrinolysis (GO:0051918) | 5.89119324 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.88739001 |
5 | L-phenylalanine metabolic process (GO:0006558) | 5.88739001 |
6 | aromatic amino acid family catabolic process (GO:0009074) | 5.55668663 |
7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.45899410 |
8 | regulation of fibrinolysis (GO:0051917) | 5.29021562 |
9 | indole-containing compound catabolic process (GO:0042436) | 5.16361449 |
10 | indolalkylamine catabolic process (GO:0046218) | 5.16361449 |
11 | tryptophan catabolic process (GO:0006569) | 5.16361449 |
12 | kynurenine metabolic process (GO:0070189) | 5.16076794 |
13 | alpha-linolenic acid metabolic process (GO:0036109) | 5.09595628 |
14 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.02873813 |
15 | protein carboxylation (GO:0018214) | 5.02873813 |
16 | tryptophan metabolic process (GO:0006568) | 4.99379185 |
17 | urea cycle (GO:0000050) | 4.96269350 |
18 | urea metabolic process (GO:0019627) | 4.96269350 |
19 | complement activation, alternative pathway (GO:0006957) | 4.86747631 |
20 | sulfur amino acid catabolic process (GO:0000098) | 4.80066545 |
21 | high-density lipoprotein particle remodeling (GO:0034375) | 4.79126092 |
22 | bile acid biosynthetic process (GO:0006699) | 4.66193561 |
23 | regulation of protein activation cascade (GO:2000257) | 4.62415366 |
24 | glyoxylate metabolic process (GO:0046487) | 4.42685905 |
25 | nitrogen cycle metabolic process (GO:0071941) | 4.40185954 |
26 | reverse cholesterol transport (GO:0043691) | 4.38206868 |
27 | phospholipid efflux (GO:0033700) | 4.35596894 |
28 | regulation of complement activation (GO:0030449) | 4.33692345 |
29 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.25966331 |
30 | bile acid metabolic process (GO:0008206) | 4.17323976 |
31 | negative regulation of sterol transport (GO:0032372) | 4.10500246 |
32 | negative regulation of cholesterol transport (GO:0032375) | 4.10500246 |
33 | intestinal cholesterol absorption (GO:0030299) | 4.06597503 |
34 | cysteine metabolic process (GO:0006534) | 4.05324546 |
35 | plasma lipoprotein particle remodeling (GO:0034369) | 4.02340113 |
36 | protein-lipid complex remodeling (GO:0034368) | 4.02340113 |
37 | macromolecular complex remodeling (GO:0034367) | 4.02340113 |
38 | acylglycerol homeostasis (GO:0055090) | 4.01020572 |
39 | triglyceride homeostasis (GO:0070328) | 4.01020572 |
40 | regulation of cholesterol homeostasis (GO:2000188) | 3.97165499 |
41 | regulation of cholesterol esterification (GO:0010872) | 3.94243176 |
42 | homocysteine metabolic process (GO:0050667) | 3.93691561 |
43 | regulation of triglyceride catabolic process (GO:0010896) | 3.90706873 |
44 | cholesterol efflux (GO:0033344) | 3.88534057 |
45 | tyrosine metabolic process (GO:0006570) | 3.87638210 |
46 | aromatic amino acid family metabolic process (GO:0009072) | 3.86898637 |
47 | plasma lipoprotein particle assembly (GO:0034377) | 3.85533004 |
48 | coenzyme catabolic process (GO:0009109) | 3.78172538 |
49 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.76372841 |
50 | serine family amino acid catabolic process (GO:0009071) | 3.73901235 |
51 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.70300708 |
52 | plasma lipoprotein particle clearance (GO:0034381) | 3.68268943 |
53 | alpha-amino acid catabolic process (GO:1901606) | 3.59572698 |
54 | indolalkylamine metabolic process (GO:0006586) | 3.58534246 |
55 | cellular modified amino acid catabolic process (GO:0042219) | 3.58032893 |
56 | valine metabolic process (GO:0006573) | 3.54179792 |
57 | phospholipid homeostasis (GO:0055091) | 3.53486853 |
58 | protein-lipid complex assembly (GO:0065005) | 3.47179261 |
59 | imidazole-containing compound metabolic process (GO:0052803) | 3.45999202 |
60 | amino-acid betaine metabolic process (GO:0006577) | 3.42300405 |
61 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.41251184 |
62 | bile acid and bile salt transport (GO:0015721) | 3.38546685 |
63 | lipoprotein metabolic process (GO:0042157) | 3.37701031 |
64 | benzene-containing compound metabolic process (GO:0042537) | 3.33575524 |
65 | cholesterol homeostasis (GO:0042632) | 3.33261675 |
66 | fibrinolysis (GO:0042730) | 3.33139582 |
67 | plasma lipoprotein particle organization (GO:0071827) | 3.32638792 |
68 | positive regulation of lipid catabolic process (GO:0050996) | 3.31580792 |
69 | sterol homeostasis (GO:0055092) | 3.31417517 |
70 | amine catabolic process (GO:0009310) | 3.30681583 |
71 | cellular biogenic amine catabolic process (GO:0042402) | 3.30681583 |
72 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.29772196 |
73 | cytolysis (GO:0019835) | 3.29568925 |
74 | lysine metabolic process (GO:0006553) | 3.28625456 |
75 | lysine catabolic process (GO:0006554) | 3.28625456 |
76 | complement activation (GO:0006956) | 3.27117192 |
77 | cellular amino acid catabolic process (GO:0009063) | 3.26534648 |
78 | cellular extravasation (GO:0045123) | 3.24849185 |
79 | low-density lipoprotein particle remodeling (GO:0034374) | 3.24786177 |
80 | proline biosynthetic process (GO:0006561) | 3.20905232 |
81 | ethanol oxidation (GO:0006069) | 3.20456770 |
82 | complement activation, classical pathway (GO:0006958) | 3.20307660 |
83 | glutamate metabolic process (GO:0006536) | 3.20285345 |
84 | detection of molecule of bacterial origin (GO:0032490) | 3.20128589 |
85 | protein activation cascade (GO:0072376) | 3.19036547 |
86 | negative regulation of lipase activity (GO:0060192) | 3.18350553 |
87 | blood coagulation, intrinsic pathway (GO:0007597) | 3.16652892 |
88 | protein-lipid complex subunit organization (GO:0071825) | 3.13781406 |
89 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.12453047 |
90 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.11378704 |
91 | glycine metabolic process (GO:0006544) | 3.08529814 |
92 | cofactor catabolic process (GO:0051187) | 3.08178925 |
93 | acute-phase response (GO:0006953) | 3.05896098 |
94 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.04576074 |
95 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.04576074 |
96 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.02944024 |
97 | positive regulation of hemostasis (GO:1900048) | 3.01304654 |
98 | positive regulation of blood coagulation (GO:0030194) | 3.01304654 |
99 | embryonic process involved in female pregnancy (GO:0060136) | 3.00259489 |
100 | cellular glucuronidation (GO:0052695) | 2.99707925 |
101 | NAD biosynthetic process (GO:0009435) | 2.99619372 |
102 | regulation of plasminogen activation (GO:0010755) | 2.97591429 |
103 | epoxygenase P450 pathway (GO:0019373) | 2.96623515 |
104 | response to muramyl dipeptide (GO:0032495) | 2.96174952 |
105 | positive regulation of coagulation (GO:0050820) | 2.92215148 |
106 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.91997432 |
107 | arginine metabolic process (GO:0006525) | 2.89657789 |
108 | protein targeting to Golgi (GO:0000042) | 2.88256746 |
109 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.86402546 |
110 | definitive hemopoiesis (GO:0060216) | 2.83818346 |
111 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.83650599 |
112 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.81673723 |
113 | response to peptidoglycan (GO:0032494) | 2.81061712 |
114 | modulation by symbiont of host immune response (GO:0052553) | 2.79481507 |
115 | positive regulation by symbiont of host defense response (GO:0052509) | 2.79481507 |
116 | modulation by symbiont of host defense response (GO:0052031) | 2.79481507 |
117 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.79481507 |
118 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.79481507 |
119 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.79481507 |
120 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.79303561 |
121 | establishment of protein localization to Golgi (GO:0072600) | 2.78989508 |
122 | negative regulation of cell killing (GO:0031342) | 2.76500717 |
123 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.76500717 |
124 | cellular response to ethanol (GO:0071361) | 2.73834221 |
125 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.71658977 |
126 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.70828612 |
127 | regulation of macrophage cytokine production (GO:0010935) | 2.70720835 |
128 | detection of other organism (GO:0098543) | 2.68706551 |
129 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.66639239 |
130 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.66639239 |
131 | regulation of gamma-delta T cell activation (GO:0046643) | 2.65904671 |
132 | negative regulation of interleukin-12 production (GO:0032695) | 2.65566817 |
133 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.63205757 |
134 | detection of external biotic stimulus (GO:0098581) | 2.62744368 |
135 | germinal center formation (GO:0002467) | 2.59176297 |
136 | response to interleukin-15 (GO:0070672) | 2.58874259 |
137 | macrophage activation involved in immune response (GO:0002281) | 2.58767721 |
138 | B cell receptor signaling pathway (GO:0050853) | 2.57819966 |
139 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.57382301 |
140 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.56475031 |
141 | response to laminar fluid shear stress (GO:0034616) | 2.49195904 |
142 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.47841500 |
143 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.46725881 |
144 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.46055523 |
145 | positive regulation of macrophage cytokine production (GO:0060907) | 2.43924709 |
146 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.42448050 |
147 | regulation of necroptotic process (GO:0060544) | 2.41559378 |
148 | regulation of B cell differentiation (GO:0045577) | 2.41462662 |
149 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.40001792 |
150 | hemoglobin metabolic process (GO:0020027) | 2.39698467 |
151 | phospholipid translocation (GO:0045332) | 2.39174935 |
152 | lipid translocation (GO:0034204) | 2.39174935 |
153 | neutrophil mediated immunity (GO:0002446) | 2.36880913 |
154 | regulation of protein polyubiquitination (GO:1902914) | 2.34888901 |
155 | positive regulation of fibroblast migration (GO:0010763) | 2.34723067 |
156 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.34478217 |
157 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.33933919 |
158 | positive regulation of B cell differentiation (GO:0045579) | 2.33778601 |
159 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.33202834 |
160 | detection of bacterium (GO:0016045) | 2.28791423 |
161 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.27370701 |
162 | leukocyte aggregation (GO:0070486) | 2.26443408 |
163 | B cell homeostasis (GO:0001782) | 2.25931464 |
164 | negative regulation of interleukin-17 production (GO:0032700) | 2.24991884 |
165 | neutrophil activation involved in immune response (GO:0002283) | 2.23945961 |
166 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.23944357 |
167 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.23745952 |
168 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.21943592 |
169 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.20913744 |
170 | cellular response to epinephrine stimulus (GO:0071872) | 2.20799450 |
171 | detection of biotic stimulus (GO:0009595) | 2.19975160 |
172 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.17372018 |
173 | response to host (GO:0075136) | 2.17372018 |
174 | response to host defenses (GO:0052200) | 2.17372018 |
175 | Rap protein signal transduction (GO:0032486) | 2.17298568 |
176 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.16137243 |
177 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.15624242 |
178 | T cell migration (GO:0072678) | 2.13946440 |
179 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.13089758 |
180 | negative thymic T cell selection (GO:0045060) | 2.12486661 |
181 | hypotonic response (GO:0006971) | 2.12086878 |
182 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.11816923 |
183 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.10828420 |
184 | response to host immune response (GO:0052572) | 2.08447299 |
185 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.08447299 |
186 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.08168800 |
187 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.07084854 |
188 | T-helper cell differentiation (GO:0042093) | 2.07084854 |
189 | interkinetic nuclear migration (GO:0022027) | 2.05455896 |
190 | negative regulation of T cell mediated immunity (GO:0002710) | 2.04874931 |
191 | macrophage activation (GO:0042116) | 2.03902801 |
192 | cellular response to interleukin-15 (GO:0071350) | 2.03732833 |
193 | myeloid leukocyte mediated immunity (GO:0002444) | 2.03698179 |
194 | cellular response to interferon-alpha (GO:0035457) | 2.03563618 |
195 | positive regulation of interferon-alpha production (GO:0032727) | 2.02965178 |
196 | negative T cell selection (GO:0043383) | 2.02938751 |
197 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.02036417 |
198 | microglial cell activation (GO:0001774) | 2.02023315 |
199 | I-kappaB phosphorylation (GO:0007252) | 2.01697715 |
200 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.01095403 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.07034748 |
2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.12898943 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.49621715 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.88363798 |
5 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 4.52488415 |
6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.30292639 |
7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.80062031 |
8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.24416343 |
9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.08321967 |
10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.04631951 |
11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.70939834 |
12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.67583652 |
13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.48660140 |
14 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.33261174 |
15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.21751264 |
16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.20823136 |
17 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.19806519 |
18 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.14448060 |
19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.05635386 |
20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.98828069 |
21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.82571400 |
22 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.80178819 |
23 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.79107811 |
24 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.79012373 |
25 | MYC_22102868_ChIP-Seq_BL_Human | 1.76757542 |
26 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.72407962 |
27 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.72405508 |
28 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.72061908 |
29 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.71933378 |
30 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.71075074 |
31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.69651668 |
32 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.66597480 |
33 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.64927286 |
34 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.62096746 |
35 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.61208912 |
36 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.61208912 |
37 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.61159897 |
38 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60981285 |
39 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.59068291 |
40 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.58506493 |
41 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.53867587 |
42 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.53545479 |
43 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.52114094 |
44 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.52078668 |
45 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.51126703 |
46 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.49518362 |
47 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.42964706 |
48 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.42065723 |
49 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.41348092 |
50 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.40986156 |
51 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.39423925 |
52 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.38862779 |
53 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.38435845 |
54 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.35761466 |
55 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.34880295 |
56 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34090619 |
57 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.33208631 |
58 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.32424547 |
59 | TP53_16413492_ChIP-PET_HCT116_Human | 1.31791114 |
60 | MAF_26560356_Chip-Seq_TH1_Human | 1.28872529 |
61 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.28166667 |
62 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.27257766 |
63 | MYB_26560356_Chip-Seq_TH1_Human | 1.25832165 |
64 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25326685 |
65 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.24107758 |
66 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.22574372 |
67 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.22467203 |
68 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.22454159 |
69 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.22365147 |
70 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.21718609 |
71 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.21173878 |
72 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.20216017 |
73 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17902457 |
74 | UTX_26944678_Chip-Seq_JUKART_Human | 1.17593462 |
75 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.17413515 |
76 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.15988934 |
77 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.15225660 |
78 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.14025621 |
79 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.13659326 |
80 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.13017286 |
81 | GATA1_19941826_ChIP-Seq_K562_Human | 1.12443997 |
82 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.12001922 |
83 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.11967973 |
84 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.11790969 |
85 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.11522808 |
86 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.11085318 |
87 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.10854739 |
88 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.10840076 |
89 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10133632 |
90 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.09961484 |
91 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.09881003 |
92 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08162130 |
93 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.08065387 |
94 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07749861 |
95 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.07638997 |
96 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.06650949 |
97 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.06114220 |
98 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.05390085 |
99 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.05390085 |
100 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.05342422 |
101 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.04744793 |
102 | GATA2_19941826_ChIP-Seq_K562_Human | 1.01994735 |
103 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.01880856 |
104 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.01571079 |
105 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.01281174 |
106 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.00918224 |
107 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.00803800 |
108 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.00646124 |
109 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.00325952 |
110 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.00275945 |
111 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98982247 |
112 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.98811889 |
113 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.97905820 |
114 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.97328044 |
115 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.96960994 |
116 | * MYB_26560356_Chip-Seq_TH2_Human | 0.96831584 |
117 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.96473986 |
118 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.96434450 |
119 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.95552968 |
120 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.95308032 |
121 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.94386364 |
122 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.93800064 |
123 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.93334497 |
124 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.93053286 |
125 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.93036015 |
126 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93014515 |
127 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.92843489 |
128 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.92735650 |
129 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91768991 |
130 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.91652151 |
131 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.91008650 |
132 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.90955076 |
133 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90804179 |
134 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.90720770 |
135 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.88811939 |
136 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.88244985 |
137 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.87324604 |
138 | SPI1_23127762_ChIP-Seq_K562_Human | 0.87240617 |
139 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86919300 |
140 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.86741585 |
141 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.86461639 |
142 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.86241326 |
143 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85692197 |
144 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.85681408 |
145 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.85627234 |
146 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.85370704 |
147 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.85072600 |
148 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.82662936 |
149 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81767492 |
150 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.81644787 |
151 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.80727395 |
152 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.76432806 |
153 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.76010768 |
154 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.75792356 |
155 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75291945 |
156 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.73327261 |
157 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.73232196 |
158 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.72096281 |
159 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.71719366 |
160 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.71067481 |
161 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.69827879 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 6.16355553 |
2 | MP0005360_urolithiasis | 5.74053874 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.33801378 |
4 | MP0005365_abnormal_bile_salt | 5.31122218 |
5 | MP0008438_abnormal_cutaneous_collagen | 3.64643096 |
6 | MP0003252_abnormal_bile_duct | 3.49159682 |
7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.33898345 |
8 | MP0003828_pulmonary_edema | 3.29928264 |
9 | MP0000569_abnormal_digit_pigmentation | 3.13030214 |
10 | MP0010329_abnormal_lipoprotein_level | 2.85666917 |
11 | MP0009840_abnormal_foam_cell | 2.51313535 |
12 | MP0001666_abnormal_nutrient_absorption | 2.42890812 |
13 | MP0003091_abnormal_cell_migration | 2.38116154 |
14 | MP0003806_abnormal_nucleotide_metabolis | 2.23810828 |
15 | MP0005083_abnormal_biliary_tract | 2.11150310 |
16 | MP0003191_abnormal_cellular_cholesterol | 2.10606552 |
17 | MP0005275_abnormal_skin_tensile | 2.04286605 |
18 | MP0000609_abnormal_liver_physiology | 2.03341925 |
19 | MP0002138_abnormal_hepatobiliary_system | 1.93016600 |
20 | MP0003868_abnormal_feces_composition | 1.92235510 |
21 | MP0001958_emphysema | 1.90734006 |
22 | MP0003705_abnormal_hypodermis_morpholog | 1.86746571 |
23 | MP0003763_abnormal_thymus_physiology | 1.77286014 |
24 | MP0005332_abnormal_amino_acid | 1.71869064 |
25 | MP0002118_abnormal_lipid_homeostasis | 1.70407485 |
26 | MP0009278_abnormal_bone_marrow | 1.68721750 |
27 | MP0003045_fibrosis | 1.68364848 |
28 | MP0000465_gastrointestinal_hemorrhage | 1.66825024 |
29 | MP0005000_abnormal_immune_tolerance | 1.61674235 |
30 | MP0010368_abnormal_lymphatic_system | 1.60603095 |
31 | MP0001851_eye_inflammation | 1.57303834 |
32 | MP0004883_abnormal_blood_vessel | 1.56805859 |
33 | MP0003221_abnormal_cardiomyocyte_apopto | 1.55490648 |
34 | MP0001545_abnormal_hematopoietic_system | 1.54600652 |
35 | MP0005397_hematopoietic_system_phenotyp | 1.54600652 |
36 | MP0003195_calcinosis | 1.50399441 |
37 | MP0005319_abnormal_enzyme/_coenzyme | 1.50375322 |
38 | MP0003300_gastrointestinal_ulcer | 1.46431494 |
39 | MP0003436_decreased_susceptibility_to | 1.44677663 |
40 | MP0001542_abnormal_bone_strength | 1.43793169 |
41 | MP0002998_abnormal_bone_remodeling | 1.41693897 |
42 | MP0002166_altered_tumor_susceptibility | 1.39915139 |
43 | MP0005164_abnormal_response_to | 1.39423093 |
44 | MP0000598_abnormal_liver_morphology | 1.35635700 |
45 | MP0003950_abnormal_plasma_membrane | 1.34713336 |
46 | MP0000685_abnormal_immune_system | 1.34622101 |
47 | MP0002723_abnormal_immune_serum | 1.32291030 |
48 | MP0005464_abnormal_platelet_physiology | 1.32190738 |
49 | MP0002148_abnormal_hypersensitivity_rea | 1.30767316 |
50 | MP0006054_spinal_hemorrhage | 1.30557538 |
51 | MP0002452_abnormal_antigen_presenting | 1.28673491 |
52 | MP0009697_abnormal_copulation | 1.27975354 |
53 | MP0002420_abnormal_adaptive_immunity | 1.26585978 |
54 | MP0001819_abnormal_immune_cell | 1.24143848 |
55 | MP0002332_abnormal_exercise_endurance | 1.23792623 |
56 | MP0004019_abnormal_vitamin_homeostasis | 1.22406023 |
57 | MP0003656_abnormal_erythrocyte_physiolo | 1.20875085 |
58 | MP0001764_abnormal_homeostasis | 1.20050894 |
59 | MP0002396_abnormal_hematopoietic_system | 1.19227098 |
60 | MP0004510_myositis | 1.16623475 |
61 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.16557515 |
62 | MP0005388_respiratory_system_phenotype | 1.15519420 |
63 | MP0002133_abnormal_respiratory_system | 1.15519420 |
64 | MP0003448_altered_tumor_morphology | 1.13803498 |
65 | MP0010352_gastrointestinal_tract_polyps | 1.09358025 |
66 | MP0008004_abnormal_stomach_pH | 1.09249707 |
67 | MP0004272_abnormal_basement_membrane | 1.09007852 |
68 | MP0003183_abnormal_peptide_metabolism | 1.07628686 |
69 | MP0004484_altered_response_of | 1.07292477 |
70 | MP0004264_abnormal_extraembryonic_tissu | 1.05090245 |
71 | MP0002877_abnormal_melanocyte_morpholog | 1.04207213 |
72 | MP0005503_abnormal_tendon_morphology | 1.04084333 |
73 | MP0002168_other_aberrant_phenotype | 1.03840679 |
74 | MP0002398_abnormal_bone_marrow | 1.03518196 |
75 | MP0002928_abnormal_bile_duct | 1.02007324 |
76 | MP0009763_increased_sensitivity_to | 1.00662930 |
77 | MP0008469_abnormal_protein_level | 0.99554181 |
78 | MP0008260_abnormal_autophagy | 0.98041741 |
79 | MP0000013_abnormal_adipose_tissue | 0.97391951 |
80 | MP0009643_abnormal_urine_homeostasis | 0.96013596 |
81 | MP0005623_abnormal_meninges_morphology | 0.94929396 |
82 | MP0003303_peritoneal_inflammation | 0.94841813 |
83 | MP0000716_abnormal_immune_system | 0.94371350 |
84 | MP0005390_skeleton_phenotype | 0.93764992 |
85 | MP0010386_abnormal_urinary_bladder | 0.93167432 |
86 | MP0009384_cardiac_valve_regurgitation | 0.92932690 |
87 | MP0001835_abnormal_antigen_presentation | 0.92677552 |
88 | MP0005220_abnormal_exocrine_pancreas | 0.92298215 |
89 | MP0002933_joint_inflammation | 0.91853752 |
90 | MP0003172_abnormal_lysosome_physiology | 0.91211453 |
91 | MP0001348_abnormal_lacrimal_gland | 0.90629193 |
92 | MP0004130_abnormal_muscle_cell | 0.89782768 |
93 | MP0005058_abnormal_lysosome_morphology | 0.89275815 |
94 | MP0002254_reproductive_system_inflammat | 0.88975683 |
95 | MP0002006_tumorigenesis | 0.85373984 |
96 | MP0000015_abnormal_ear_pigmentation | 0.85259149 |
97 | MP0004084_abnormal_cardiac_muscle | 0.85037752 |
98 | MP0005671_abnormal_response_to | 0.84389386 |
99 | MP0001853_heart_inflammation | 0.83889466 |
100 | MP0002722_abnormal_immune_system | 0.83656820 |
101 | MP0005334_abnormal_fat_pad | 0.83470498 |
102 | MP0006138_congestive_heart_failure | 0.82721179 |
103 | MP0009764_decreased_sensitivity_to | 0.82412355 |
104 | MP0005408_hypopigmentation | 0.82333966 |
105 | MP0005023_abnormal_wound_healing | 0.82288258 |
106 | MP0002128_abnormal_blood_circulation | 0.81451656 |
107 | MP0002419_abnormal_innate_immunity | 0.81347979 |
108 | MP0000639_abnormal_adrenal_gland | 0.80964023 |
109 | MP0001879_abnormal_lymphatic_vessel | 0.78616013 |
110 | MP0002127_abnormal_cardiovascular_syste | 0.78417654 |
111 | MP0001915_intracranial_hemorrhage | 0.78080527 |
112 | MP0003795_abnormal_bone_structure | 0.77053162 |
113 | MP0005647_abnormal_sex_gland | 0.76813809 |
114 | MP0000858_altered_metastatic_potential | 0.75801038 |
115 | MP0001845_abnormal_inflammatory_respons | 0.75181568 |
116 | MP0005621_abnormal_cell_physiology | 0.75158751 |
117 | MP0009642_abnormal_blood_homeostasis | 0.75139261 |
118 | MP0005025_abnormal_response_to | 0.73886667 |
119 | MP0003724_increased_susceptibility_to | 0.73684063 |
120 | MP0009765_abnormal_xenobiotic_induced | 0.72926134 |
121 | MP0002078_abnormal_glucose_homeostasis | 0.72536729 |
122 | MP0003279_aneurysm | 0.71632357 |
123 | MP0005167_abnormal_blood-brain_barrier | 0.71571948 |
124 | MP0002971_abnormal_brown_adipose | 0.70234149 |
125 | MP0005387_immune_system_phenotype | 0.70104596 |
126 | MP0001790_abnormal_immune_system | 0.70104596 |
127 | MP0004808_abnormal_hematopoietic_stem | 0.69677334 |
128 | MP0005670_abnormal_white_adipose | 0.69520958 |
129 | MP0000371_diluted_coat_color | 0.69256151 |
130 | MP0010155_abnormal_intestine_physiology | 0.69207154 |
131 | MP0000767_abnormal_smooth_muscle | 0.68055454 |
132 | MP0005084_abnormal_gallbladder_morpholo | 0.67771661 |
133 | MP0008057_abnormal_DNA_replication | 0.67685418 |
134 | MP0002009_preneoplasia | 0.66898918 |
135 | MP0004947_skin_inflammation | 0.65653867 |
136 | MP0003075_altered_response_to | 0.65408723 |
137 | MP0003943_abnormal_hepatobiliary_system | 0.64890112 |
138 | MP0002060_abnormal_skin_morphology | 0.64765921 |
139 | MP0005376_homeostasis/metabolism_phenot | 0.64646116 |
140 | MP0003638_abnormal_response/metabolism_ | 0.64457838 |
141 | MP0001800_abnormal_humoral_immune | 0.64087917 |
142 | MP0009115_abnormal_fat_cell | 0.63806660 |
143 | MP0000249_abnormal_blood_vessel | 0.63482494 |
144 | MP0005174_abnormal_tail_pigmentation | 0.61875667 |
145 | MP0002405_respiratory_system_inflammati | 0.61481531 |
146 | MP0005076_abnormal_cell_differentiation | 0.61376805 |
147 | MP0006082_CNS_inflammation | 0.61262096 |
148 | MP0009785_altered_susceptibility_to | 0.61104277 |
149 | MP0003566_abnormal_cell_adhesion | 0.59258979 |
150 | MP0000689_abnormal_spleen_morphology | 0.58777573 |
151 | MP0005075_abnormal_melanosome_morpholog | 0.57411894 |
152 | MP0004782_abnormal_surfactant_physiolog | 0.57410537 |
153 | MP0001533_abnormal_skeleton_physiology | 0.55896177 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 6.17217870 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.61107911 |
3 | Intrahepatic cholestasis (HP:0001406) | 5.51496126 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.05380191 |
5 | Prolonged partial thromboplastin time (HP:0003645) | 5.04524122 |
6 | Xanthomatosis (HP:0000991) | 4.90237172 |
7 | Complement deficiency (HP:0004431) | 4.76934301 |
8 | Hypobetalipoproteinemia (HP:0003563) | 4.75462745 |
9 | Abnormality of the common coagulation pathway (HP:0010990) | 4.19215490 |
10 | Epidermoid cyst (HP:0200040) | 4.07967616 |
11 | Joint hemorrhage (HP:0005261) | 4.04528381 |
12 | Spondylolisthesis (HP:0003302) | 3.91970085 |
13 | Hyperlipoproteinemia (HP:0010980) | 3.73903949 |
14 | Hypoglycemic coma (HP:0001325) | 3.71019045 |
15 | Abnormality of the intrinsic pathway (HP:0010989) | 3.69922029 |
16 | Abnormality of complement system (HP:0005339) | 3.69627712 |
17 | Hypercholesterolemia (HP:0003124) | 3.43777472 |
18 | Aortic aneurysm (HP:0004942) | 3.42505500 |
19 | Protrusio acetabuli (HP:0003179) | 3.41694466 |
20 | Hypolipoproteinemia (HP:0010981) | 3.41607227 |
21 | Hypochromic microcytic anemia (HP:0004840) | 3.36213865 |
22 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.34651494 |
23 | Ketosis (HP:0001946) | 3.31533574 |
24 | Myocardial infarction (HP:0001658) | 3.27097307 |
25 | Vascular tortuosity (HP:0004948) | 3.26609396 |
26 | Abnormality of methionine metabolism (HP:0010901) | 3.26111626 |
27 | Arterial tortuosity (HP:0005116) | 3.23003990 |
28 | Aortic dissection (HP:0002647) | 3.20526544 |
29 | Fat malabsorption (HP:0002630) | 3.14900918 |
30 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.12863929 |
31 | Systemic lupus erythematosus (HP:0002725) | 3.11621011 |
32 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.06727820 |
33 | Spontaneous hematomas (HP:0007420) | 3.06099581 |
34 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.00581092 |
35 | Eczematoid dermatitis (HP:0000976) | 2.98288358 |
36 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.96743852 |
37 | Hyperammonemia (HP:0001987) | 2.95558858 |
38 | Skin nodule (HP:0200036) | 2.89746323 |
39 | Hypoalphalipoproteinemia (HP:0003233) | 2.89470830 |
40 | Spinal cord lesions (HP:0100561) | 2.71310357 |
41 | Syringomyelia (HP:0003396) | 2.71310357 |
42 | Hypoglycemic seizures (HP:0002173) | 2.70697817 |
43 | Thoracolumbar scoliosis (HP:0002944) | 2.67455681 |
44 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.67273108 |
45 | Polycythemia (HP:0001901) | 2.66757464 |
46 | Hepatocellular carcinoma (HP:0001402) | 2.66648744 |
47 | Papillary thyroid carcinoma (HP:0002895) | 2.64256779 |
48 | Absent frontal sinuses (HP:0002688) | 2.64023399 |
49 | Dilatation of the ascending aorta (HP:0005111) | 2.63238704 |
50 | Premature rupture of membranes (HP:0001788) | 2.63035435 |
51 | Overgrowth (HP:0001548) | 2.62955360 |
52 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.61436235 |
53 | Gingival bleeding (HP:0000225) | 2.60295103 |
54 | Glomerulonephritis (HP:0000099) | 2.59542461 |
55 | Esophageal varix (HP:0002040) | 2.57763516 |
56 | Ketoacidosis (HP:0001993) | 2.54031996 |
57 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.50149388 |
58 | Hyperbilirubinemia (HP:0002904) | 2.49991051 |
59 | Recurrent abscess formation (HP:0002722) | 2.49151029 |
60 | Abnormal platelet volume (HP:0011876) | 2.47203607 |
61 | Conjugated hyperbilirubinemia (HP:0002908) | 2.46307800 |
62 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.45351629 |
63 | Increased mean platelet volume (HP:0011877) | 2.45061290 |
64 | T lymphocytopenia (HP:0005403) | 2.43595510 |
65 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.43558643 |
66 | Mitral stenosis (HP:0001718) | 2.42491945 |
67 | Abnormality of T cell number (HP:0011839) | 2.39830330 |
68 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.39655718 |
69 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.39655718 |
70 | Hematochezia (HP:0002573) | 2.38494598 |
71 | Hyperglycinemia (HP:0002154) | 2.36472465 |
72 | Orchitis (HP:0100796) | 2.35057108 |
73 | Myositis (HP:0100614) | 2.32541845 |
74 | Menorrhagia (HP:0000132) | 2.31416199 |
75 | Recurrent cutaneous fungal infections (HP:0011370) | 2.31293968 |
76 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.31293968 |
77 | Mitral valve prolapse (HP:0001634) | 2.31280338 |
78 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.28977067 |
79 | Acanthocytosis (HP:0001927) | 2.28648502 |
80 | Testicular neoplasm (HP:0010788) | 2.28303275 |
81 | Delayed CNS myelination (HP:0002188) | 2.27981921 |
82 | Thrombophlebitis (HP:0004418) | 2.27233821 |
83 | Spontaneous abortion (HP:0005268) | 2.25952992 |
84 | Abnormality of nucleobase metabolism (HP:0010932) | 2.25504659 |
85 | Osteolytic defects of the hand bones (HP:0009699) | 2.24345583 |
86 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.24345583 |
87 | Subacute progressive viral hepatitis (HP:0006572) | 2.24299706 |
88 | Nephritis (HP:0000123) | 2.23546239 |
89 | Gingivitis (HP:0000230) | 2.22994285 |
90 | Epistaxis (HP:0000421) | 2.22503297 |
91 | Steatorrhea (HP:0002570) | 2.18992096 |
92 | Wormian bones (HP:0002645) | 2.18468187 |
93 | Pulmonary embolism (HP:0002204) | 2.16449448 |
94 | Retrobulbar optic neuritis (HP:0100654) | 2.15709798 |
95 | Optic neuritis (HP:0100653) | 2.15709798 |
96 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.14469552 |
97 | Abnormality of the peritoneum (HP:0002585) | 2.13247509 |
98 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.12855056 |
99 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.10513289 |
100 | Abnormality of glycine metabolism (HP:0010895) | 2.10513289 |
101 | Recurrent fungal infections (HP:0002841) | 2.06078108 |
102 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.05336373 |
103 | Hyperglycinuria (HP:0003108) | 2.05237704 |
104 | Hypoplasia of the iris (HP:0007676) | 2.03233523 |
105 | Facial diplegia (HP:0001349) | 2.03156479 |
106 | Spastic diplegia (HP:0001264) | 2.02419361 |
107 | Scanning speech (HP:0002168) | 2.00614798 |
108 | Ulnar bowing (HP:0003031) | 2.00422413 |
109 | Metaphyseal dysplasia (HP:0100255) | 1.99835490 |
110 | Hemorrhage of the eye (HP:0011885) | 1.99184226 |
111 | Pulmonary infiltrates (HP:0002113) | 1.96978428 |
112 | Gastrointestinal infarctions (HP:0005244) | 1.96700596 |
113 | Asymmetric septal hypertrophy (HP:0001670) | 1.94460178 |
114 | Recurrent skin infections (HP:0001581) | 1.94091971 |
115 | Turricephaly (HP:0000262) | 1.93610262 |
116 | Soft skin (HP:0000977) | 1.92325881 |
117 | Narrow palate (HP:0000189) | 1.92047970 |
118 | Stomatitis (HP:0010280) | 1.91715855 |
119 | Fatigue (HP:0012378) | 1.91437479 |
120 | Papilledema (HP:0001085) | 1.89897462 |
121 | Hyperglycemia (HP:0003074) | 1.89343216 |
122 | Aneurysm (HP:0002617) | 1.89131118 |
123 | Chest pain (HP:0100749) | 1.88607582 |
124 | Autoimmune hemolytic anemia (HP:0001890) | 1.88607068 |
125 | Thickened calvaria (HP:0002684) | 1.88368122 |
126 | Abnormality of purine metabolism (HP:0004352) | 1.87966443 |
127 | Abnormality of the frontal sinuses (HP:0002687) | 1.87733577 |
128 | Lower limb hyperreflexia (HP:0002395) | 1.86032546 |
129 | Abnormality of macrophages (HP:0004311) | 1.84996908 |
130 | Mucopolysacchariduria (HP:0008155) | 1.83848636 |
131 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.83848636 |
132 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.83087247 |
133 | Prolonged bleeding time (HP:0003010) | 1.82160818 |
134 | Broad ribs (HP:0000885) | 1.81555328 |
135 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.81372344 |
136 | Abnormality of iron homeostasis (HP:0011031) | 1.80819746 |
137 | Mediastinal lymphadenopathy (HP:0100721) | 1.80690603 |
138 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.80020348 |
139 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.79956565 |
140 | Subaortic stenosis (HP:0001682) | 1.79956565 |
141 | Slow saccadic eye movements (HP:0000514) | 1.77978209 |
142 | Microcytic anemia (HP:0001935) | 1.77700586 |
143 | Hypochromic anemia (HP:0001931) | 1.77492288 |
144 | Symptomatic seizures (HP:0011145) | 1.76928278 |
145 | Genu recurvatum (HP:0002816) | 1.76405314 |
146 | Hypoplasia of the thymus (HP:0000778) | 1.75496943 |
147 | Abnormality of the right ventricle (HP:0001707) | 1.75109340 |
148 | Dysostosis multiplex (HP:0000943) | 1.74483586 |
149 | Increased CSF protein (HP:0002922) | 1.73827219 |
150 | Increased variability in muscle fiber diameter (HP:0003557) | 1.73648416 |
151 | Thyroid carcinoma (HP:0002890) | 1.72998204 |
152 | Cerebral aneurysm (HP:0004944) | 1.72753796 |
153 | Thin bony cortex (HP:0002753) | 1.72697726 |
154 | Cellulitis (HP:0100658) | 1.71320960 |
155 | Conjunctival telangiectasia (HP:0000524) | 1.70982707 |
156 | Vascular calcification (HP:0004934) | 1.70666593 |
157 | Lymphangioma (HP:0100764) | 1.70001036 |
158 | Coarse hair (HP:0002208) | 1.69810226 |
159 | Thrombocytosis (HP:0001894) | 1.69198853 |
160 | Joint laxity (HP:0001388) | 1.69025635 |
161 | Arterial thrombosis (HP:0004420) | 1.69020595 |
162 | Peritonitis (HP:0002586) | 1.68937824 |
163 | Pulmonic stenosis (HP:0001642) | 1.68770164 |
164 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.66607739 |
165 | Vasculitis (HP:0002633) | 1.66296608 |
166 | Stroke (HP:0001297) | 1.65399516 |
167 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.65186435 |
168 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.65186435 |
169 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.65186435 |
170 | Ovoid vertebral bodies (HP:0003300) | 1.64664827 |
171 | Abnormal foot bone ossification (HP:0010675) | 1.64258995 |
172 | Osteomyelitis (HP:0002754) | 1.63322996 |
173 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.62826205 |
174 | Recurrent bacterial skin infections (HP:0005406) | 1.62796715 |
175 | Joint swelling (HP:0001386) | 1.62147737 |
176 | Leukocytosis (HP:0001974) | 1.62031656 |
177 | Vertebral compression fractures (HP:0002953) | 1.61996445 |
178 | Periodontitis (HP:0000704) | 1.61838166 |
179 | Recurrent viral infections (HP:0004429) | 1.61747362 |
180 | Acute myeloid leukemia (HP:0004808) | 1.61739399 |
181 | Upper motor neuron abnormality (HP:0002127) | 1.61599101 |
182 | Hemoptysis (HP:0002105) | 1.61526431 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PKN2 | 3.71899078 |
2 | ERN1 | 3.33713982 |
3 | TRIB3 | 3.03674298 |
4 | INSRR | 2.91260199 |
5 | FLT3 | 2.84274514 |
6 | TGFBR2 | 2.53141691 |
7 | PRPF4B | 2.47227604 |
8 | TAOK3 | 2.44973915 |
9 | MAP3K10 | 2.42106591 |
10 | FGFR4 | 2.40966547 |
11 | AKT3 | 2.26560791 |
12 | BMPR2 | 2.17016977 |
13 | SIK1 | 2.14921043 |
14 | ICK | 2.12999003 |
15 | PTK6 | 1.97160724 |
16 | MAP3K6 | 1.96660618 |
17 | IKBKE | 1.92019470 |
18 | TGFBR1 | 1.90013429 |
19 | RIPK4 | 1.77422568 |
20 | CSK | 1.73053002 |
21 | IRAK1 | 1.71569776 |
22 | MAP2K3 | 1.70689539 |
23 | TYK2 | 1.70264719 |
24 | CDK12 | 1.67038679 |
25 | DYRK1B | 1.46607269 |
26 | PDGFRA | 1.44062537 |
27 | RIPK1 | 1.42746855 |
28 | BCKDK | 1.42601833 |
29 | FGFR3 | 1.41032820 |
30 | BRD4 | 1.39125936 |
31 | MAP3K2 | 1.36683754 |
32 | NLK | 1.34847097 |
33 | PIK3CA | 1.34632352 |
34 | FRK | 1.33652859 |
35 | SGK2 | 1.31506908 |
36 | MAP4K1 | 1.31011518 |
37 | ERBB3 | 1.30223802 |
38 | FES | 1.30104391 |
39 | MYLK | 1.28354868 |
40 | SIK3 | 1.24181919 |
41 | CSF1R | 1.23696023 |
42 | LRRK2 | 1.23329285 |
43 | EPHB1 | 1.20978441 |
44 | CDK6 | 1.19265225 |
45 | IRAK4 | 1.17649697 |
46 | LATS1 | 1.17345200 |
47 | GRK6 | 1.16622053 |
48 | CAMK1D | 1.15552668 |
49 | MATK | 1.14840251 |
50 | EEF2K | 1.12815506 |
51 | TIE1 | 1.12019825 |
52 | MAPK15 | 1.10337434 |
53 | JAK3 | 1.10174804 |
54 | MAPK11 | 1.09947211 |
55 | CAMKK2 | 1.09568144 |
56 | BTK | 1.09480391 |
57 | EIF2AK3 | 1.06418994 |
58 | YES1 | 1.06051000 |
59 | JAK1 | 1.05014590 |
60 | EPHA3 | 1.03993241 |
61 | JAK2 | 1.02131889 |
62 | MAP3K7 | 1.01538978 |
63 | STK10 | 1.01460601 |
64 | KIT | 0.97707471 |
65 | DDR2 | 0.91308910 |
66 | MAP3K11 | 0.90263982 |
67 | FGFR2 | 0.86137247 |
68 | IKBKB | 0.85907057 |
69 | MAP3K14 | 0.85896151 |
70 | TBK1 | 0.85748712 |
71 | STK38 | 0.85235689 |
72 | ITK | 0.85154287 |
73 | CAMK1G | 0.84956548 |
74 | RET | 0.84054639 |
75 | ZAP70 | 0.84039860 |
76 | PIM1 | 0.84013989 |
77 | PRKAA2 | 0.83649665 |
78 | HIPK2 | 0.83096287 |
79 | STK3 | 0.82734410 |
80 | SYK | 0.79689003 |
81 | MAP2K6 | 0.78245425 |
82 | IRAK2 | 0.76884173 |
83 | TAOK2 | 0.75970988 |
84 | WNK1 | 0.75633196 |
85 | PDGFRB | 0.75515190 |
86 | MTOR | 0.74406315 |
87 | TEC | 0.74099379 |
88 | MAP3K1 | 0.73990122 |
89 | PAK3 | 0.73286286 |
90 | GRK7 | 0.73267657 |
91 | MELK | 0.73230375 |
92 | PRKD2 | 0.73189798 |
93 | MARK2 | 0.71550595 |
94 | BCR | 0.69950659 |
95 | MAPK4 | 0.69752777 |
96 | KSR2 | 0.68139377 |
97 | MAP3K12 | 0.68048756 |
98 | TRPM7 | 0.67567257 |
99 | STK38L | 0.67349816 |
100 | BLK | 0.67111008 |
101 | PIK3CG | 0.64751228 |
102 | CDK7 | 0.63870575 |
103 | TYRO3 | 0.63164629 |
104 | CHUK | 0.61592848 |
105 | FER | 0.60367583 |
106 | STK24 | 0.60307529 |
107 | PDK1 | 0.60027260 |
108 | RPS6KA6 | 0.59713241 |
109 | RPS6KL1 | 0.59252530 |
110 | RPS6KC1 | 0.59252530 |
111 | TNK2 | 0.58700091 |
112 | BMX | 0.58344619 |
113 | PTK2 | 0.58204404 |
114 | CLK1 | 0.58172102 |
115 | PTK2B | 0.57904712 |
116 | MAP2K4 | 0.57834718 |
117 | TXK | 0.56742281 |
118 | SGK3 | 0.55385775 |
119 | KSR1 | 0.54520868 |
120 | IRAK3 | 0.54504311 |
121 | NUAK1 | 0.54217507 |
122 | HCK | 0.53982988 |
123 | TAOK1 | 0.52529623 |
124 | PRKD1 | 0.52253235 |
125 | MAP3K3 | 0.51557364 |
126 | MAP3K13 | 0.51366879 |
127 | MAPK7 | 0.50023373 |
128 | NEK9 | 0.49827073 |
129 | FGR | 0.48977428 |
130 | ABL1 | 0.48647570 |
131 | CDK4 | 0.48622879 |
132 | RPS6KA2 | 0.48556401 |
133 | PRKAA1 | 0.48343522 |
134 | MAP3K5 | 0.48305821 |
135 | KDR | 0.47002950 |
136 | ACVR1B | 0.46736743 |
137 | LCK | 0.45504634 |
138 | PRKD3 | 0.45202036 |
139 | EGFR | 0.45189349 |
140 | PRKCH | 0.43136159 |
141 | LYN | 0.42734340 |
142 | MAPK12 | 0.42638643 |
143 | GSK3A | 0.41801286 |
144 | MAPK3 | 0.40937514 |
145 | TTN | 0.39791120 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.46458688 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.48472283 |
3 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.14272183 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.12928456 |
5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.10527347 |
6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.95589457 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.65238185 |
8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.42052635 |
9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.24813906 |
10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.15912781 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.13753772 |
12 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.10274802 |
13 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.06709404 |
14 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.06324708 |
15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.03571507 |
16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.88865983 |
17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.83469559 |
18 | ABC transporters_Homo sapiens_hsa02010 | 1.81124261 |
19 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.76334288 |
20 | Peroxisome_Homo sapiens_hsa04146 | 1.76325507 |
21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.75718871 |
22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.62137989 |
23 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.62020179 |
24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.61857641 |
25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.60179075 |
26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.54990442 |
27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.54060687 |
28 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.51464724 |
29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.51305810 |
30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.48925729 |
31 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.46304612 |
32 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.45932757 |
33 | Bile secretion_Homo sapiens_hsa04976 | 1.45294344 |
34 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.39116440 |
35 | Histidine metabolism_Homo sapiens_hsa00340 | 1.38899840 |
36 | Malaria_Homo sapiens_hsa05144 | 1.38317014 |
37 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.38145669 |
38 | Lysine degradation_Homo sapiens_hsa00310 | 1.37694572 |
39 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.35163010 |
40 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.34683270 |
41 | Measles_Homo sapiens_hsa05162 | 1.33918854 |
42 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33782951 |
43 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.33541854 |
44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.33194740 |
45 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.32036266 |
46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.30240692 |
47 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.26595466 |
48 | Hepatitis B_Homo sapiens_hsa05161 | 1.26193904 |
49 | Tuberculosis_Homo sapiens_hsa05152 | 1.25810907 |
50 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.25281217 |
51 | Retinol metabolism_Homo sapiens_hsa00830 | 1.25226085 |
52 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.23722677 |
53 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.19609012 |
54 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.18500923 |
55 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.18332815 |
56 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.15865737 |
57 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.14004768 |
58 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.11470707 |
59 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.10245704 |
60 | Prostate cancer_Homo sapiens_hsa05215 | 1.09473711 |
61 | Influenza A_Homo sapiens_hsa05164 | 1.09234395 |
62 | Endometrial cancer_Homo sapiens_hsa05213 | 1.07770375 |
63 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.07495521 |
64 | Shigellosis_Homo sapiens_hsa05131 | 1.02555686 |
65 | Hepatitis C_Homo sapiens_hsa05160 | 1.02358120 |
66 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.01369089 |
67 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.98754822 |
68 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.98306232 |
69 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.97875314 |
70 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.97063666 |
71 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.96607453 |
72 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.96494369 |
73 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.96190809 |
74 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.94230794 |
75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.91788007 |
76 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.91184835 |
77 | Glioma_Homo sapiens_hsa05214 | 0.91030558 |
78 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.89033571 |
79 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.88281198 |
80 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.86204069 |
81 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.86113332 |
82 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.85290164 |
83 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84073535 |
84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.83888472 |
85 | Colorectal cancer_Homo sapiens_hsa05210 | 0.83787476 |
86 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.83675402 |
87 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.83360308 |
88 | Allograft rejection_Homo sapiens_hsa05330 | 0.83039269 |
89 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.82039721 |
90 | Insulin resistance_Homo sapiens_hsa04931 | 0.81224743 |
91 | Circadian rhythm_Homo sapiens_hsa04710 | 0.81115239 |
92 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.80266225 |
93 | Salmonella infection_Homo sapiens_hsa05132 | 0.73854460 |
94 | Viral myocarditis_Homo sapiens_hsa05416 | 0.71879704 |
95 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.71786411 |
96 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.71631785 |
97 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.71380570 |
98 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.70647993 |
99 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.70628195 |
100 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.70473158 |
101 | Phagosome_Homo sapiens_hsa04145 | 0.70010133 |
102 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69509343 |
103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68774110 |
104 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.68342010 |
105 | Melanoma_Homo sapiens_hsa05218 | 0.67929947 |
106 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.67789921 |
107 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.67649520 |
108 | Apoptosis_Homo sapiens_hsa04210 | 0.66718949 |
109 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.65351491 |
110 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.65031314 |
111 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.64323145 |
112 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.63977954 |
113 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.63666920 |
114 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.63224363 |
115 | Endocytosis_Homo sapiens_hsa04144 | 0.62767954 |
116 | Long-term potentiation_Homo sapiens_hsa04720 | 0.61475356 |
117 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61397511 |
118 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.60477786 |
119 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.59394564 |
120 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.59263750 |
121 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.57137461 |
122 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57070247 |
123 | Pathways in cancer_Homo sapiens_hsa05200 | 0.57007863 |
124 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.55908084 |
125 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.55717458 |
126 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.55110582 |
127 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.54481818 |
128 | Carbon metabolism_Homo sapiens_hsa01200 | 0.54303615 |
129 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53722338 |
130 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.53002842 |
131 | Other glycan degradation_Homo sapiens_hsa00511 | 0.52461448 |
132 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.52421989 |
133 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.51058384 |
134 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46614617 |
135 | Sulfur relay system_Homo sapiens_hsa04122 | 0.43982771 |
136 | Galactose metabolism_Homo sapiens_hsa00052 | 0.43181183 |
137 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.43058808 |
138 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.42692724 |
139 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.39583363 |
140 | Leishmaniasis_Homo sapiens_hsa05140 | 0.37642465 |
141 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.36228502 |
142 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.32935716 |
143 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.30675834 |
144 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.29711079 |
145 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28745104 |
146 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.28420403 |
147 | Pertussis_Homo sapiens_hsa05133 | 0.28382759 |
148 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.28078817 |
149 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.27876989 |
150 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.26738225 |
151 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.25935842 |
152 | Prion diseases_Homo sapiens_hsa05020 | 0.24098376 |
153 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.22786066 |
154 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.22725450 |
155 | Legionellosis_Homo sapiens_hsa05134 | 0.21776656 |
156 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.20709565 |
157 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.20451325 |
158 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.20117269 |
159 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.19250128 |
160 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.19201573 |
161 | Platelet activation_Homo sapiens_hsa04611 | 0.18731188 |
162 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.18644843 |
163 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.17735551 |
164 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.17575061 |
165 | Adherens junction_Homo sapiens_hsa04520 | 0.17573488 |
166 | Amoebiasis_Homo sapiens_hsa05146 | 0.15756014 |
167 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.15528533 |
168 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.14612635 |
169 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.13160370 |
170 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.12977153 |
171 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.12536221 |
172 | Focal adhesion_Homo sapiens_hsa04510 | 0.12245460 |